Related Experiment Videos

Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators

T Andersson¹, C G Regårdh, M L Dahl-Puustinen

¹Research Laboratories, AB Hässle, Mölndal, Sweden.

Therapeutic Drug Monitoring

|July 1, 1990

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Qualitative and quantitative comparison of allergen component-specific to birch and grass analyzed by ImmunoCAP assay and Euroline immunoblot test.

European annals of allergy and clinical immunology·2022

Pre-treatment allergen-specific IgE analysis and outcomes of allergen immunotherapy.

European annals of allergy and clinical immunology·2021

Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4β-hydroxycholesterol during efavirenz treatment and efavirenz/rifampicin co-treatment.

The Journal of antimicrobial chemotherapy·2014

The action of fenfluramine andp-chloramphetamine on serotonergic mechanisms: A comparative study in rat brain nuclei.

Neurochemical research·2013

Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patients.

The pharmacogenomics journal·2012

UGT1A4*3 encodes significantly increased glucuronidation of olanzapine in patients on maintenance treatment and in recombinant systems.

Clinical pharmacology and therapeutics·2012

See all related articles